Authors are invited to submit abstracts for the upcoming 23^rd International Myeloma Society Annual Meeting, held September 23-26, 2026 in Glasgow, Scotland.

During the prestigious IMS Annual Meeting, myeloma experts from around the world gather to discuss basic, preclinical, and clinical aspects of multiple myeloma. Abstracts presenting new research or expanding existing studies are encouraged. Only finalized submissions will be evaluated.

All abstracts will be blinded and peer reviewed. Authors will be notified in early July 2025 if their abstract has been accepted. Presenting authors must register for the Annual Meeting.

Abstract submissions are also invited for the 9th Nursing and Allied Health Symposium. Select the “Nursing and Allied Health” track when submitting.

Oral Abstract – Limited number selected for oral presentation.

Poster Abstract – Physical posters presented during dedicated sessions.

Nursing and Allied Health – Submit for the 9th Nursing and Allied Health Symposium.

Include name, email address, and institutional affiliation for all co-authors (maximum of 25). Identify one presenting author per abstract.

An automatic email will be sent to all authors to verify their information. Authors submitting multiple abstracts should plan for alternate presenters.

Responsibility of Abstract Submitters

• Commitment to present if accepted
• Encore abstracts permitted; new data encouraged
• Consent required for use of recognizable images
• Compliance with IRB or equivalent research standards

Responsibility of Abstract Presenters

• Present the abstract if accepted
• Disclose financial and non-financial relationships
• Review presentation guidelines and RSVP acceptance
• Register for the IMS Annual Meeting